Tempus AI, Inc. - TEM Income before deduction of interest, taxes and amortization
Operating profit dynamics illustrate the path of Tempus AI, Inc (TEM) toward stable cash flow through AI-driven genomic analysis. The company's advantage lies in colossal datasets that create a barrier to entry for competitors. Diagnostic reliability is ensured by costly cold-chain transportation of biomaterials. The 0.00 mark serves as a current indicator, allowing investors to recognize the capital consolidation phase and assess the actual volume of cash from sales.
Tempus AI, Inc. (TEM) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization information:
- business debt structure and liquidity details:
- business earnings and investment ratios data:
TEM - Net Profit|Expected Net Profit Tempus AI, Inc|TEM - Price to Earnings Ratio|Projected Price to Earnings tempus.com|TEM - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Tempus|TEM - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Tempus|TEM - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth tempus.com|TEM - Net earnings per share growth this year|Projected earnings per share increase next year Tempus AI, Inc
Analysis of all company metrics:Tempus AI, Inc - TEM
Tempus AI, Inc (TEM) dominance in precision medicine, driven by unique genomic data sets, directly impacts operational efficiency dynamics. This metric captures the actual cash balance of earnings before interest, taxes, depreciation, and amortization, reflecting the current balance of market demand. EBITDA analytics demonstrate volatility in investor sentiment, transforming raw figures into an indicator of market euphoria or panic. Blindly following the chart trend risks unjustified portfolio drawdowns. Fundamental profit growth confirms the resilience of the business model and the long-term value of the assets.
Who Tempus AI, Inc competes with
Operating income before deduction of amortization Qiagen Corp (QGEN)|IONS: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RGEN (repligen.com)|RNA: Operating profit EBITDA|CRISPR Therapeutics Inc (CRSP) - Operating profit EBITDA|WGS (Sema4) - Operating profit EBITDA|Ultragenyx Corp (RARE) - Operating income before deduction of amortization|Operating profit before deduction of amortization BEAM (Beam Therapeutics Inc.)|SRPT (sarepta.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TWST (Twist Bioscience, Inc.)|Operating income before deduction of amortization 10x Genomics Inc (TXG)|NTLA - Profit before payment of interest, taxes and amortization|STOK (Stoke Corp) - Operating profit before amortization|BLFS: Operating profit EBITDA|Operating profit before deduction of amortization wavelifesciences.com|Operating profit before deduction of amortization MAZE|SION (Sionna Therapeutics, Inc.) - Company profit before taxes, interest and amortization|Operating profit EBITDA PRME|TSHA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization uniQure N.V. QURE|MGTX - Operating profit before deduction of amortization|REGENXBIO - Operating profit EBITDA|SLDB (Solid Biosciences Inc) - Operating profit before amortization|Ocugen Corp (OCGN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PACB|BNTC (Benitec Biopharma Inc.) - Operating profit EBITDA|Operating profit EBITDA designtx.com|Operating profit before deduction of amortization RCKT (Rocket Pharmaceuticals, Inc.)|Company profit before taxes, interest and amortization FDMT|Operating profit EBITDA LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. (KRRO) - Profit before interest, taxes and amortization|EDIT - Profit before payment of interest, taxes and amortization|silence-therapeutics.com (SLN) - Operating profit before deduction of amortization|proqr.com (PRQR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization CDXS (Codexis)|Operating profit before deduction of amortization SGMO|Operating profit EBITDA Nautilus Biotechnology Inc|Profit before payment of interest, taxes and amortization Metagenomi, Inc. (MGX)|Operating income before deduction of amortization precisionbiosciences.com|Generation Bio - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization BOLD|Exicure Corp - Operating profit EBITDA|IMNN - Operating profit EBITDA|PHIO: Operating profit EBITDA|MBIO - Operating income before deduction of amortization|Operating profit before deduction of amortization RNAZ|BNGO: Income before deduction of interest, taxes and amortization|Operating profit EBITDA APDN|Operating income before deduction of amortization bluebird bio, Inc|Profit before payment of interest, taxes and amortization ImmunoPrecise Antibodies Ltd. IPA|OMGA: Operating profit before amortization|Singular Genomics - Operating profit EBITDA|Regulus Therapeutics, Inc. (RGLS) - Operating profit before deduction of amortization|SYRS (Syros) - Operating profit before deduction of amortization|TBIO: Company profit before taxes, interest and amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|Profit before interest, taxes and amortization unitybiotechnology.com UBX
